Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635 Life Science Investing
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications Life Science Investing
ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman Life Science Investing
Aytu BioPharma Announces Commercial Availability of EXXUA Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults Life Science Investing
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance Life Science Investing
Spruce Biosciences Appoints Proven Pharmaceutical Commercial Leader Keli Walbert to Board of Directors Life Science Investing
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Life Science Investing
BioVaxys Strengthens Scientific Team with Addition of Former IMV Vice President of R&D Life Science Investing
